Evolution of tined leadless pacemaker implantation: Patient selection, implant volume, center characteristics, and safety trends
Heart Rhythm · 2026-10
DOI: 10.1016/j.hrthm.2026.10.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Heart Rhythm, 2026-10. Verfasst von Jonathan P Piccini und 4 weiteren Autor:innen. Beteiligte Einrichtung: Cardiac Electrophysiology Section, Duke University Medical Center & Duke Clinical Research Institute, Durham, North Carolina. Electronic address: jon…. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medtronic Inc.
Abstract (Originalsprache)
BACKGROUND: As leadless pacing approaches a decade in clinical practice, we sought to assess how device complications have changed over time and how variations in patient, implanter volume, and facility characteristics are associated with these changes. OBJECTIVE: The aim of this study is to evaluate rates of cardiac perforation after leadless pacemaker implantation over time and the associations between patient, implanter volume, and facility characteristics and these outcomes, including the extent of variation attributable to implanters and facilities. METHODS: Medicare claims linked to a manufacturer's device registration data were used to identify patients implanted with a tined leadless pacemaker from 2017 to 2024. Patient selection across implanters and facilities was evaluated by determining differences in patient characteristics and their impact on patient-adjusted model estimates. Random-intercept models were fitted to estimate the variation attributable to implanters and facilities. RESULTS: Among 46,698 implants, 19,446 (41.6%) were Micra AV; patients had a mean age of 80.4 years and a high Charlson Comorbidity Index (4.7 ± 3.4). Cardiac perforation rates declined over time (adjusted coefficient, -0.13; 95% confidence interval -0.19 to -0.06; P < .01). Higher implanter volume was associated with fewer perforations (odds ratio, 0.93 per additional 10 implants; 95% confidence interval, 0.88-0.98; P < .01). Differences in patient characteristics across providers and facilities were observed; however, adjustment for these differences did not materially alter the associations between implanters and facility and perforation rates. CONCLUSION: In Medicare patients with tined leadless pacemakers, cardiac perforation rates declined over time and were lower in those implanted by more experienced implanters. Variation in outcomes was more closely associated with implanters than with facilities.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Cardiac Electrophysiology Section, Duke University Medical Center & Duke Clinical Research Institute, Durham, North Carolina. Electronic address: jonathan.piccini@duke.edu.
- Health Economics and Outcomes Research, Electrophysiology Therapies, Medtronic, Inc, Minneapolis, Minnesota.
- Vanderbilt University Medical Center, Vanderbilt Heart and Vascular Institute, Nashville, Tennessee.
- Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
Förderung
- Medtronic Inc
Zitieren
APA
Piccini, J. P., Higuera, L., Yang, Y., Crossley, G., & El-Chami, M. F. (2026). Evolution of tined leadless pacemaker implantation: Patient selection, implant volume, center characteristics, and safety trends. Heart Rhythm. https://doi.org/10.1016/j.hrthm.2026.10.014
Vancouver
Piccini JP, Higuera L, Yang Y, Crossley G, El-Chami MF. Evolution of tined leadless pacemaker implantation: Patient selection, implant volume, center characteristics, and safety trends. Heart Rhythm. 2026. doi:10.1016/j.hrthm.2026.10.014
BibTeX
@article{Piccini2026,
author = {Piccini, Jonathan P and Higuera, Lucas and Yang, Yunshu and Crossley, George and El-Chami, Mikhael F},
title = {Evolution of tined leadless pacemaker implantation: Patient selection, implant volume, center characteristics, and safety trends},
journal = {Heart Rhythm},
year = {2026},
doi = {10.1016/j.hrthm.2026.10.014}
}
EUVIMED